CSS
VRCA icon

Cubist Systematic Strategies’s Verrica Pharmaceuticals VRCA Stock Holding History

Cubist Systematic Strategies’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-196
Closed -$1.04K – 4034
2025
Q2 		$1.04K Buy
+196
New +$1.05K ﹤0.01% 2884
2023
Q2 		– Sell
-1,736
Closed -$113K – 4397
2023
Q1 		$113K Buy
+1,736
New +$105K ﹤0.01% 3418
2022
Q4 		– Sell
-942
Closed -$28K – 4620
2022
Q3 		$28K Buy
942
+822
+685% +$28.2K ﹤0.01% 4202
2022
Q2 		$2K Buy
+120
New +$6.03K ﹤0.01% 4320
2019
Q1 		– Sell
-43
Closed -$3K – 2434
2018
Q4 		$3K Sell
43
-148
-77% -$18K ﹤0.01% 2005
2018
Q3 		$31K Buy
+191
New +$32.6K ﹤0.01% 1765

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return